Scinai Immunotherapeutics Ltd. Annual Weighted Average Number of Shares Outstanding, Basic from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Scinai Immunotherapeutics Ltd. annual/quarterly Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2023.
  • Scinai Immunotherapeutics Ltd. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 1.35B shares, a 81% increase year-over-year.
  • Scinai Immunotherapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.56B shares, a 107% increase from 2022.
  • Scinai Immunotherapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 754M shares, a 33.6% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 1.56B +809M +107% Jan 1, 2023 Dec 31, 2023 20-F 2024-05-15
2022 754M +190M +33.6% Jan 1, 2022 Dec 31, 2022 20-F 2024-05-15
2021 565M Jan 1, 2021 Dec 31, 2021 20-F 2024-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.